Evidence map›Paper›PMID 28759611›Full record

ArticlePLoS pathogens2017

TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus.

Yashaswini Kannan, Lewis J Entwistle, Victoria S Pelly, Jimena Perez-Lloret, Alan W Walker, Steven C Ley, Mark S Wilson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yashaswini KannanAllergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.
Lewis J EntwistleAllergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.
Victoria S PellyAllergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.
Jimena Perez-LloretAllergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.
Alan W WalkerPathogen Genomics Group, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.ORCID http://orcid.org/0000-0001-5099-8495
Steven C LeyImmune Cell Signaling Laboratory, The Francis Crick Institute, United Kingdom.
Mark S WilsonAllergy and Anti-helminth Immunity Laboratory, The Francis Crick Institute, London, United Kingdom.ORCID http://orcid.org/0000-0003-1737-1281
The Francis Crick Institute · GBUniversity of Aberdeen · GB

Funding

Medical Research Council MC_U117584209Wellcome Trust
6 · The paper itself

Abstract

TPL-2 (COT, MAP3K8) kinase activates the MEK1/2-ERK1/2 MAPK signaling pathway in innate immune responses following TLR, TNFR1 and IL-1R stimulation. TPL-2 contributes to type-1/Th17-mediated autoimmunity and control of intracellular pathogens. We recently demonstrated TPL-2 reduces severe airway allergy to house dust mite by negatively regulating type-2 responses. In the present study, we found that TPL-2 deficiency resulted in resistance to Heligmosomoides polygyrus infection, with accelerated worm expulsion, reduced fecal egg burden and reduced worm fitness. Using co-housing experiments, we found resistance to infection in TPL-2 deficient mice (Map3k8-/-) was independent of microbiota alterations in H. polygyrus infected WT and Map3k8-/-mice. Additionally, our data demonstrated immunity to H. polygyrus infection in TPL-2 deficient mice was not due to dysregulated type-2 immune responses. Genome-wide analysis of intestinal tissue from infected TPL-2-deficient mice identified elevated expression of genes involved in chemotaxis and homing of leukocytes and cells, including Ccl24 and alternatively activated genes. Indeed, Map3k8-/-mice had a significant influx of eosinophils, neutrophils, monocytes and Il4GFP+ T cells. Conditional knockout experiments demonstrated that specific deletion of TPL-2 in CD11c+ cells, but not Villin+ epithelial cells, LysM+ myeloid cells or CD4+ T cells, led to accelerated resistance to H. polygyrus. In line with a central role of CD11c+ cells, CD11c+ CD11b+ cells isolated from TPL-2-deficient mice had elevated Ccl24. Finally, Ccl24 neutralization in TPL-2 deficient mice significantly decreased the expression of Arg1, Retnla, Chil3 and Ear11 correlating with a loss of resistance to H. polygyrus. These observations suggest that TPL-2-regulated Ccl24 in CD11c+CD11b+ cells prevents accelerated type-2 mediated immunity to H. polygyrus. Collectively, this study identifies a previously unappreciated role for TPL-2 controlling immune responses to H. polygyrus infection by restricting Ccl24 production.

Indexed as

AnimalsChemokine CCL24FemaleHumansImmunity, InnateMaleMAP Kinase Kinase KinasesMiceMice, Inbred C57BLMice, KnockoutNematospiroides dubiusProto-Oncogene ProteinsStrongylida InfectionsTh2 CellsCcl24 protein, mouseChemokine CCL24Map3k8 protein, mouseMAP Kinase Kinase KinasesProto-Oncogene Proteins

Identifiers

PMID28759611
PMCPMC5560741
OpenAlexW2740368380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.